901 related articles for article (PubMed ID: 34373744)
1. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
Li Z; Sun C; Qin Z
Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
3. The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators.
Ilkhani K; Bastami M; Delgir S; Safi A; Talebian S; Alivand MR
Anticancer Agents Med Chem; 2021; 21(2):254-266. PubMed ID: 32914721
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
[TBL] [Abstract][Full Text] [Related]
5. Stromal reprogramming: A target for tumor therapy.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Dec; 239():117049. PubMed ID: 31730862
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
7. 'Reverse Warburg effect' of cancer‑associated fibroblasts (Review).
Liang L; Li W; Li X; Jin X; Liao Q; Li Y; Zhou Y
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35425996
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
Sazeides C; Le A
Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
Front Immunol; 2023; 14():1152312. PubMed ID: 37033960
[TBL] [Abstract][Full Text] [Related]
11. Mapping the Metabolic Networks of Tumor Cells and Cancer-Associated Fibroblasts.
Karta J; Bossicard Y; Kotzamanis K; Dolznig H; Letellier E
Cells; 2021 Feb; 10(2):. PubMed ID: 33540679
[TBL] [Abstract][Full Text] [Related]
12. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells.
Yan W; Wu X; Zhou W; Fong MY; Cao M; Liu J; Liu X; Chen CH; Fadare O; Pizzo DP; Wu J; Liu L; Liu X; Chin AR; Ren X; Chen Y; Locasale JW; Wang SE
Nat Cell Biol; 2018 May; 20(5):597-609. PubMed ID: 29662176
[TBL] [Abstract][Full Text] [Related]
13. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
14. Metabolic alterations in the tumor microenvironment and their role in oncogenesis.
Eisenberg L; Eisenberg-Bord M; Eisenberg-Lerner A; Sagi-Eisenberg R
Cancer Lett; 2020 Aug; 484():65-71. PubMed ID: 32387442
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
16. Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.
Jung JG; Le A
Adv Exp Med Biol; 2018; 1063():167-178. PubMed ID: 29946783
[TBL] [Abstract][Full Text] [Related]
17. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer fibroblasts and cross-talk.
Magesh P; Thankachan S; Venkatesh T; Suresh PS
Clin Chim Acta; 2021 Oct; 521():158-169. PubMed ID: 34270953
[TBL] [Abstract][Full Text] [Related]
19. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming of the tumour microenvironment.
Xing Y; Zhao S; Zhou BP; Mi J
FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]